Trial Profile
A Multicenter, Randomized, Double-blind, Parallel-group, Evaluation of 12 Weeks of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children 6 to 17 Years of Age With Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Valsartan (Primary) ; Enalapril
- Indications Hypertension
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 27 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database. (EudraCT2006-005260-88)
- 27 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database. (EudraCT2006-005260-88)
- 07 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database. (EudraCT2006-005408-14)